slides · global inventory
Table Data
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 16,285
Current window 9,121-9,150
Pages 543
Rows per page 30
Tool
9,121-9,150 of 16,285
42
Includes geographic store distribution and regional revenue mix, alongside quarterly performance tables.Kering | Investor Presentation Deck | 63 slides · Kering
Conference presentation Investor relations 1 hit
15
The slide includes a disclaimer regarding the non-head-to-head nature of the comparison.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
17
The slide includes a disclaimer regarding the non-head-to-head nature of the comparison.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
18
The slide highlights a favorable safety profile with no serious adverse events (SAEs) or drug-related infections.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations Beat · TractionLoop · Quick Win Big Bet1 hit
25
The table displays adverse events occurring in 2 or more patients. Data includes patient counts and percentages for both 'All' and 'Related' adverse events.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
26
Includes a line chart showing plasma concentration over time and a table summarizing PK parameters (Cmax, AUClast, Vd, CL, t1/2).Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
33
Includes three dose-response curves and a comparative table of clinical stage and potency metrics.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
35
Includes a visual representation of the dose escalation study design and a detailed table of patient baseline characteristics.Kymera | Investor Presentation Deck | 41 slides · Kymera
Pitch deck Investor relations 1 hit
15
Lenovo | Results Presentation Deck | 18 slidesLenovo | Results Presentation Deck | 18 slides · Lenovo
Conference presentation Investor relations Beat · Appendix1 hit
24
Includes specific financial footnotes regarding 10-Q/10-K reporting and calculation methodology.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
25
Includes a detailed footnote explaining the use of non-GAAP financial measures and specific restructuring costs.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
26
Includes detailed line-item adjustments such as stock-based compensation, impairment, and transition costs.Limbach Holdings | Investor Presentation Deck | 28 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
18
Includes footnotes regarding FX rates and borrowing base calculations.Lion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations Beat · Financials1 hit
21
Includes detailed reconciliation table and numbered footnotes explaining adjustments.Lion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations 1 hit
25
Lion Electric | Investor Presentation Deck | 30 slidesLion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations 1 hit
26
Lion Electric | Investor Presentation Deck | 30 slidesLion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations 1 hit
27
Lion Electric | Investor Presentation Deck | 30 slidesLion Electric | Investor Presentation Deck | 30 slides · Lion Electric
Pitch deck Investor relations 1 hit
18
Includes detailed footnotes explaining adjustments to EBITDA.Lion Electric | Results Presentation Deck | 21 slides · Lion Electric
Conference presentation Investor relations 1 hit
17
The slide provides a comprehensive snapshot of the company's financial health and debt obligations.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
18
The slide includes a detailed disclaimer regarding the assumptions and non-GAAP measures used in the outlook.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Financials1 hit
24
Slide 24 of a corporate presentation.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · SolutionLoop · Voice Of Customer1 hit
26
Includes a map of Europe with color-coded regions and location markers.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Market Size1 hit
28
Includes a combo chart showing revenue, EBITDA, and EBITDA margin trend.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
29
Includes a map of locations, a table of operational metrics, a list of competitors, and a stacked bar chart of revenue.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Beat · Competition1 hit
15
The slide compares the safety profile of THIO against standard of care (SOC) chemotherapy.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
17
Data presented in a table format with footnotes explaining the methodology for DCR calculation.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
18
DCR = Disease Control Rate. Data shows high efficacy across all tested dose levels.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
25
The slide compares clinical trial data for three different treatment regimens in CRC patients.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
38
Includes detailed breakdown of investment income, expenses, non-cash compensation, and net asset changes.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
39
The table tracks the bridge from beginning NAV to ending NAV per share, including income, expenses, dividends, and share issuance impacts.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit